Cargando…

Molecular docking analysis of doronine derivatives with human COX-2

Cyclooxygenase-2 (COX-2) is linked to inflammation. Therefore, it is of interest to design and develop novel inhibitors for COX-2. Hence, we report the molecular docking based binding features of doronine derivatives (desacetyldoronine, floradnin, onetine, 22310115, 21159807) with the human Cyclooxy...

Descripción completa

Detalles Bibliográficos
Autores principales: Hussain, Sardar, Guruvayoorappan, Chandrasekharan, Komal, KP, Ennaganti, Sreenivasa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Biomedical Informatics 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7452741/
https://www.ncbi.nlm.nih.gov/pubmed/32884214
http://dx.doi.org/10.6026/97320630016483
_version_ 1783575218421235712
author Hussain, Sardar
Guruvayoorappan, Chandrasekharan
Komal, KP
Ennaganti, Sreenivasa
author_facet Hussain, Sardar
Guruvayoorappan, Chandrasekharan
Komal, KP
Ennaganti, Sreenivasa
author_sort Hussain, Sardar
collection PubMed
description Cyclooxygenase-2 (COX-2) is linked to inflammation. Therefore, it is of interest to design and develop novel inhibitors for COX-2. Hence, we report the molecular docking based binding features of doronine derivatives (desacetyldoronine, floradnin, onetine, 22310115, 21159807) with the human Cyclooxygenase-2 as potential inhibitors. A pyrrolizidine alkaloid doronine a molecular constituents of Emilia sonchifolia is an herbal alternative to known drugs in the prophylaxis of inflammation. We report the molecular docking, pharmacophore, ADMET and molecular properties analysis data of doronine and its similar compounds. Docking and ADMET Data shows that COX-2 binds with doronine with optimal features for further consideration.
format Online
Article
Text
id pubmed-7452741
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Biomedical Informatics
record_format MEDLINE/PubMed
spelling pubmed-74527412020-09-02 Molecular docking analysis of doronine derivatives with human COX-2 Hussain, Sardar Guruvayoorappan, Chandrasekharan Komal, KP Ennaganti, Sreenivasa Bioinformation Research Article Cyclooxygenase-2 (COX-2) is linked to inflammation. Therefore, it is of interest to design and develop novel inhibitors for COX-2. Hence, we report the molecular docking based binding features of doronine derivatives (desacetyldoronine, floradnin, onetine, 22310115, 21159807) with the human Cyclooxygenase-2 as potential inhibitors. A pyrrolizidine alkaloid doronine a molecular constituents of Emilia sonchifolia is an herbal alternative to known drugs in the prophylaxis of inflammation. We report the molecular docking, pharmacophore, ADMET and molecular properties analysis data of doronine and its similar compounds. Docking and ADMET Data shows that COX-2 binds with doronine with optimal features for further consideration. Biomedical Informatics 2020-06-30 /pmc/articles/PMC7452741/ /pubmed/32884214 http://dx.doi.org/10.6026/97320630016483 Text en © 2020 Biomedical Informatics http://creativecommons.org/licenses/by/3.0/ This is an Open Access article which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. This is distributed under the terms of the Creative Commons Attribution License.
spellingShingle Research Article
Hussain, Sardar
Guruvayoorappan, Chandrasekharan
Komal, KP
Ennaganti, Sreenivasa
Molecular docking analysis of doronine derivatives with human COX-2
title Molecular docking analysis of doronine derivatives with human COX-2
title_full Molecular docking analysis of doronine derivatives with human COX-2
title_fullStr Molecular docking analysis of doronine derivatives with human COX-2
title_full_unstemmed Molecular docking analysis of doronine derivatives with human COX-2
title_short Molecular docking analysis of doronine derivatives with human COX-2
title_sort molecular docking analysis of doronine derivatives with human cox-2
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7452741/
https://www.ncbi.nlm.nih.gov/pubmed/32884214
http://dx.doi.org/10.6026/97320630016483
work_keys_str_mv AT hussainsardar moleculardockinganalysisofdoroninederivativeswithhumancox2
AT guruvayoorappanchandrasekharan moleculardockinganalysisofdoroninederivativeswithhumancox2
AT komalkp moleculardockinganalysisofdoroninederivativeswithhumancox2
AT ennagantisreenivasa moleculardockinganalysisofdoroninederivativeswithhumancox2